Our results showed that CD4+ TLEX-CD8086 cells more effectively attenuated tumor growth and prolonged the survival time of L1210 cell-bearing mice than LEX-CD8086 and CD4+ TLEX-null cells did. Here, CD4 is linked to neoplasm.